Company Filing History:
Years Active: 2020-2022
Title: Helene Bon: Innovator in Antibody Therapeutics
Introduction
Helene Bon is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, her work focuses on innovative solutions for treating various diseases.
Latest Patents
Helene Bon's latest patents include antagonist antibodies that bind to human TGFB1, TGFB2, and TGFB3, specifically for the treatment of lung fibrosis. The present disclosure relates to TGF-beta antibodies and binding fragments thereof, DNA encoding the same, host cells comprising said DNA, and methods of expressing the antibody or binding fragment in a host cell. The disclosure also extends to pharmaceutical compositions comprising the antibody or a binding fragment thereof, and the use of the antibody, binding fragment, and compositions in the treatment of various diseases, including fibrosis.
Career Highlights
Helene Bon is currently associated with Ucb Biopharma Srl, where she continues to advance her research and development efforts. Her work has been instrumental in the progress of antibody therapeutics, contributing to the understanding and treatment of complex diseases.
Collaborations
Some of her notable coworkers include Joanne Elizabeth Compson and Kate Louise Dixon, who collaborate with her in various research initiatives.
Conclusion
Helene Bon's innovative work in the field of antibody therapeutics showcases her dedication to improving healthcare through scientific advancements. Her contributions are paving the way for new treatment options for patients suffering from serious conditions.